You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Estrogens, Conjugated (USP)

Showing 26 - 50 of 539
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrophic Vaginitis, Menopause, Recurrent Urinary Tract Infections Trial in Louisville (Conjugated equine estrogen topical cream,

Completed
  • Atrophic Vaginitis
  • +2 more
  • Conjugated equine estrogen topical cream
  • Apricot kernel oil
  • Louisville, Kentucky
    Health Care Outpatient Center and Springs Medical Center
May 13, 2021

Menopause Trial in Baton Rouge (TSEC (Tissue-selective estrogen complexes), Placebo)

Completed
  • Menopause
  • TSEC (Tissue-selective estrogen complexes)
  • Placebo
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Jan 19, 2022

Effect of ADT in Prostate Cancer Asia (READT Asia Study)

Recruiting
  • Prostate Cancer
  • Androgen deprivation therapy - bilateral orchidectomy
  • +2 more
  • Shatin, Hong Kong
    Prince of Wales Hospital
Dec 14, 2021

Overactive Bladder Trial in Maywood (conjugated estrogen)

Completed
Has Results
  • Overactive Bladder
  • conjugated estrogen
  • Maywood, Illinois
    Loyola University Medical Center
Mar 22, 2021

Anticoagulant Trial (Heparin)

Not yet recruiting
  • Anticoagulant
  • Heparin
  • (no location specified)
Mar 15, 2023

Anticoagulant Trial (Heparin)

Not yet recruiting
  • Anticoagulant
  • Heparin
  • (no location specified)
Mar 15, 2023

Pneumococcal Vaccines Trial (12-Valent Pneumococcal Conjugate Vaccine)

Not yet recruiting
  • Pneumococcal Vaccines
  • 12-Valent Pneumococcal Conjugate Vaccine
  • (no location specified)
Jan 31, 2023

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

Ureter Injury Trial (Saline Injection 0.9%, Indigotindisulfonate sodium 0.8%)

Not yet recruiting
  • Ureter Injury
  • Saline Injection 0.9%
  • Indigotindisulfonate sodium 0.8%
  • (no location specified)
Oct 12, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Vaginitis Atropic, Pelvic Organ Prolapse, Endometrial Hyperplasia Trial (Conjugated Estrogen, Promestriene, Estriol)

Completed
  • Vaginitis Atropic
  • +2 more
  • Conjugated Estrogen
  • +3 more
  • (no location specified)
Apr 29, 2019

Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

Active, not recruiting
  • Metastatic Breast Cancer
  • Springfield, Massachusetts
  • +2 more
Nov 1, 2022

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Detroit, Petoskey

Completed
  • Stage I Prostate Adenocarcinoma
  • +2 more
  • Antiandrogen Therapy
  • +3 more
  • Detroit, Michigan
  • +2 more
Oct 4, 2020

Benign Prostatic Hyperplasia Trial in United States (Group-1 (15mg, OPK-88004), Group-2 (25 mg,OPK-88004), Placebo)

Terminated
Has Results
  • Benign Prostatic Hyperplasia
  • Group-1 (15mg, OPK-88004)
  • +2 more
  • Anniston, Alabama
  • +14 more
Aug 23, 2021

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
Has Results
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Cancer, Breast, Cancer, Lung, Cancer of Pancreas Trial in Fairfax, Beijing (CBP-1019)

Active, not recruiting
  • Cancer, Breast
  • +4 more
  • Fairfax, Virginia
  • +1 more
Apr 13, 2023

Menopausal Syndromes Trial in Banqiao (Tibolone, Estradiol & medroxyprogesterone acetate)

Completed
  • Menopausal Syndromes
  • Tibolone
  • Estradiol & medroxyprogesterone acetate
  • Banqiao, New Taipei, Taiwan
    Far Eastern Memorial Hospital
Feb 7, 2022

Breast Cancer Trial (Disitamab Vedotin+Anlotinib)

Not yet recruiting
  • Breast Cancer
  • Disitamab Vedotin+Anlotinib
  • (no location specified)
Aug 14, 2023

Ankle Osteoarthritis Trial in Astana (Injection of biocomposite hydrogel into ankle's cartilage lesion under arthroscopic

Recruiting
  • Ankle Osteoarthritis
  • Injection of biocomposite hydrogel into ankle's cartilage lesion under arthroscopic control
  • Microfracture of ankle's cartilage lesion under arthroscopic control
  • Astana, Kazakhstan
    Center of National Scientific center Of Traumatology and Orthope
Aug 31, 2023

Cervical Cancer, Sexual Dysfunction, Quality of Life Trial in Barcelona, Madrid (Multimodal intervention on sexual dysfunction

Not yet recruiting
  • Cervical Cancer
  • +2 more
  • Multimodal intervention on sexual dysfunction and quality-of-life
  • Barcelona, Spain
  • +1 more
Sep 4, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Palliative Care in COVID-19: Analysis of Costs of

Not yet recruiting
  • COVID-19
  • Palliative Care
  • Analysis of costs with patient care during hospitalization
  • (no location specified)
Jun 12, 2023

Ureter Injury Trial (Indigotindisulfonate sodium 0.8%, Saline injection 0.9%)

Not yet recruiting
  • Ureter Injury
  • Indigotindisulfonate sodium 0.8%
  • Saline injection 0.9%
  • (no location specified)
Sep 19, 2023

s on Leukocyte Distribution, Monocyte Function and Platelet

Recruiting
  • Arteriosclerosis
  • +3 more
    • Düsseldorf, Germany
      University-Hospital Düsseldorf Division of Cardiology, Pulmonary
    Aug 2, 2023